Skip Navigation

Community Health Needs Assessment Reporting

  • Dana-Farber Cancer Institute's Community Benefits activities are informed by the Institute's Community Health Needs Assessment (CHNA) and Community Health Improvement Planning (CHIP) process, conducted every three years to gain a greater understanding of the health issues facing Boston residents. The following documents fulfill the Institute's CHNA/CHIP obligations as required under Internal Revenue Code Section 501(r)(3)(A)(iii) and the Patient Protection and Affordable Care Act and supported by the Attorney General's (AGO) Community Benefits Guidelines. The findings of the CHNA reports below have validated Dana-Farber's past and current Community Benefits activities, while identifying opportunities for future initiatives and continued community engagement.

    In 2019, Dana-Farber collaborated with multiple stakeholders to conduct the first city-wide assessment and improvement plan through the Boston CHNA/CHIP Collaborative. The 2019 Boston Collaborative CHNA provides a comprehensive look at a range of health outcomes and conditions in Boston, as well as the social determinants that affect health. The full report is available at www.bostonchna.org. In 2019, Dana-Farber also collaborated with Boston Medical Center (BMC) to develop a cancer-specific CHNA report that provides a deeper analysis of issues across the cancer continuum. The health equity analysis used for this assessment confirms the substantial burden of cancer and other health disparities across DFCI's priority neighborhoods.

    As an NCI-designated comprehensive cancer center, Dana-Farber is uniquely qualified to demonstrate measurable outcomes in reducing the cancer burden by building on existing Community Benefits activities and marshaling the collective efforts of local partners who share our mission. To achieve racial/ethnic health equity across the cancer continuum, Dana-Farber's Community Benefits Office will continue to focus on the following areas:

    1. Addressing the cancer burden
    2. Reducing access barriers
    3. Promoting survivorship, particularly among communities of color

    These areas reflect a commitment to meeting the health needs of medically underserved populations in DFCI's priority neighborhoods and leveraging the hospital's unique role in the continuum of care as a comprehensive cancer center. Additional priorities will emerge through Dana-Farber's Implementation Plan, which will be completed in November 2019.

    Dana-Farber's CHNA documents are available for public review and comment through the links below. For more information, please contact Magnolia Contreras, Director of Community Benefits at Dana-Farber Cancer Institute, at magnolia_contreras@dfci.harvard.edu or 617-632-3462.

    2020-2023 Community Health Needs Assessment

    Cancer CHNA Executive Summary
    Cancer CHNA Report
    Boston CHNA Report

    2016-2019 Community Health Needs Assessment

    CHNA Report
    CHNA Implementation Plan

    2012-2015 Community Health Needs Assessment

    CHNA Executive Summary
    CHNA Implementation Plan

    Massachusetts Attorney General Community Benefits Reports

    Community Benefits 2018 Report
    Community Benefits 2017 Report